US Stock MarketDetailed Quotes

BRTX Biorestorative Therapies

Watchlist
  • 1.480
  • +0.115+8.42%
Close May 6 16:00 ET
  • 1.460
  • -0.020-1.35%
Pre 07:06 ET
10.02MMarket Cap-432P/E (TTM)

Biorestorative Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-8.75%-6.43M
-9.76%-1.77M
18.87%-1.18M
9.66%-1.13M
-47.29%-2.35M
-77.58%-5.91M
-41.11%-1.62M
-130.65%-1.45M
-68.65%-1.25M
-95.97%-1.59M
Net income from continuing operations
22.06%-14.42M
35.02%-2.83M
37.16%-2.93M
36.25%-2.98M
-18.02%-5.68M
58.25%-18.49M
78.69%-4.35M
-11.27%-4.66M
-15.08%-4.68M
69.23%-4.82M
Operating gains losses
-648.73%-569.07K
----
----
----
----
-100.47%-76K
----
----
----
----
Depreciation and amortization
37.49%165.74K
34.34%42.71K
34.97%42.15K
31.77%41.53K
51.29%39.35K
35.28%120.55K
47.91%31.79K
44.71%31.23K
44.34%31.52K
7.48%26.01K
Other non cash items
200.48%90.31K
-95.51%3.28K
0.00%29.01K
0.00%29.01K
113.13%29.01K
-107.07%-89.88K
-22.29%73.09K
-92.28%29.01K
-92.34%29.01K
-152.37%-220.99K
Change In working capital
3,543.42%515.33K
138.48%129.06K
186.66%141.93K
9.08%283K
-195.25%-38.66K
-95.64%14.14K
-54.75%-335.4K
-78.55%49.51K
4,358.02%259.44K
-87.18%40.59K
-Change in receivables
70.00%-3.3K
-31.03%20K
50.69%-14.3K
---9K
--0
-191.67%-11K
866.67%29K
-514.29%-29K
--0
-1,000.00%-11K
-Change in prepaid assets
-20.86%57.85K
394.20%20.7K
320.82%77.63K
-106.34%-10.51K
71.21%-29.97K
122.10%73.1K
98.26%-7.04K
-19.12%18.45K
701.37%165.79K
-447.52%-104.1K
-Change in payables and accrued expense
421.03%600.1K
144.22%124.77K
26.23%113.94K
173.91%336.8K
-86.64%24.6K
-84.53%115.18K
-233.78%-282.18K
-60.19%90.26K
536.97%122.96K
-36.00%184.13K
-Change in other current liabilities
14.59%-139.33K
51.58%-36.41K
-17.03%-35.34K
-17.03%-34.3K
-17.03%-33.29K
-61.21%-163.13K
-184.36%-75.19K
-17.65%-30.19K
40.29%-29.31K
---28.44K
Cash from discontinued investing activities
Operating cash flow
-8.75%-6.43M
-9.76%-1.77M
18.87%-1.18M
9.66%-1.13M
-47.29%-2.35M
-77.58%-5.91M
-41.11%-1.62M
-130.65%-1.45M
-68.65%-1.25M
-95.97%-1.59M
Investing cash flow
Cash flow from continuing investing activities
124.27%3.25M
103.10%100.67K
99.77%-23.06K
583.61%665.8K
2,389.46%2.51M
-43,607.53%-13.4M
-10,480.11%-3.24M
-9.91M
-137.67K
-109.57K
Net PPE purchase and sale
35.51%-171.04K
-64.45%-70.02K
-148.56%-11.95K
78.90%-29.05K
45.22%-60.02K
-765.10%-265.22K
-38.89%-42.58K
--24.61K
---137.67K
---109.57K
Net intangibles purchase and sale
--0
----
----
----
----
---175K
----
----
----
----
Net investment purchase and sale
126.41%3.42M
105.64%170.69K
99.89%-11.11K
--694.85K
--2.57M
---12.96M
---3.03M
---9.93M
--0
--0
Cash from discontinued investing activities
Investing cash flow
124.27%3.25M
103.10%100.67K
99.77%-23.06K
583.61%665.8K
2,389.46%2.51M
-43,607.53%-13.4M
-10,480.11%-3.24M
---9.91M
---137.67K
---109.57K
Financing cash flow
Cash flow from continuing financing activities
2.35M
85.64K
1.85M
0
0
0
Net common stock issuance
--2.35M
--85.64K
--1.85M
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--2.35M
--85.64K
--1.85M
--411.7K
--0
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
-91.85%1.71M
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-92.03%1.68M
586.11%21.03M
481.84%6.57M
919.49%17.93M
672.62%19.32M
586.11%21.03M
Current changes in cash
95.72%-826.83K
67.34%-1.59M
105.75%653.22K
96.20%-52.82K
109.38%159.89K
-207.52%-19.31M
-124.42%-4.86M
-1,705.09%-11.36M
-87.21%-1.39M
-202.32%-1.7M
End cash Position
-48.25%886.95K
-48.25%886.95K
-62.93%2.44M
-90.05%1.78M
-90.50%1.84M
-91.85%1.71M
-91.85%1.71M
481.84%6.57M
919.49%17.93M
672.62%19.32M
Free cash flow
-3.90%-6.6M
-0.56%-1.84M
16.63%-1.19M
16.52%-1.16M
-41.34%-2.41M
-89.06%-6.35M
-55.93%-1.83M
-126.74%-1.43M
-87.21%-1.39M
-109.44%-1.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -8.75%-6.43M-9.76%-1.77M18.87%-1.18M9.66%-1.13M-47.29%-2.35M-77.58%-5.91M-41.11%-1.62M-130.65%-1.45M-68.65%-1.25M-95.97%-1.59M
Net income from continuing operations 22.06%-14.42M35.02%-2.83M37.16%-2.93M36.25%-2.98M-18.02%-5.68M58.25%-18.49M78.69%-4.35M-11.27%-4.66M-15.08%-4.68M69.23%-4.82M
Operating gains losses -648.73%-569.07K-----------------100.47%-76K----------------
Depreciation and amortization 37.49%165.74K34.34%42.71K34.97%42.15K31.77%41.53K51.29%39.35K35.28%120.55K47.91%31.79K44.71%31.23K44.34%31.52K7.48%26.01K
Other non cash items 200.48%90.31K-95.51%3.28K0.00%29.01K0.00%29.01K113.13%29.01K-107.07%-89.88K-22.29%73.09K-92.28%29.01K-92.34%29.01K-152.37%-220.99K
Change In working capital 3,543.42%515.33K138.48%129.06K186.66%141.93K9.08%283K-195.25%-38.66K-95.64%14.14K-54.75%-335.4K-78.55%49.51K4,358.02%259.44K-87.18%40.59K
-Change in receivables 70.00%-3.3K-31.03%20K50.69%-14.3K---9K--0-191.67%-11K866.67%29K-514.29%-29K--0-1,000.00%-11K
-Change in prepaid assets -20.86%57.85K394.20%20.7K320.82%77.63K-106.34%-10.51K71.21%-29.97K122.10%73.1K98.26%-7.04K-19.12%18.45K701.37%165.79K-447.52%-104.1K
-Change in payables and accrued expense 421.03%600.1K144.22%124.77K26.23%113.94K173.91%336.8K-86.64%24.6K-84.53%115.18K-233.78%-282.18K-60.19%90.26K536.97%122.96K-36.00%184.13K
-Change in other current liabilities 14.59%-139.33K51.58%-36.41K-17.03%-35.34K-17.03%-34.3K-17.03%-33.29K-61.21%-163.13K-184.36%-75.19K-17.65%-30.19K40.29%-29.31K---28.44K
Cash from discontinued investing activities
Operating cash flow -8.75%-6.43M-9.76%-1.77M18.87%-1.18M9.66%-1.13M-47.29%-2.35M-77.58%-5.91M-41.11%-1.62M-130.65%-1.45M-68.65%-1.25M-95.97%-1.59M
Investing cash flow
Cash flow from continuing investing activities 124.27%3.25M103.10%100.67K99.77%-23.06K583.61%665.8K2,389.46%2.51M-43,607.53%-13.4M-10,480.11%-3.24M-9.91M-137.67K-109.57K
Net PPE purchase and sale 35.51%-171.04K-64.45%-70.02K-148.56%-11.95K78.90%-29.05K45.22%-60.02K-765.10%-265.22K-38.89%-42.58K--24.61K---137.67K---109.57K
Net intangibles purchase and sale --0-------------------175K----------------
Net investment purchase and sale 126.41%3.42M105.64%170.69K99.89%-11.11K--694.85K--2.57M---12.96M---3.03M---9.93M--0--0
Cash from discontinued investing activities
Investing cash flow 124.27%3.25M103.10%100.67K99.77%-23.06K583.61%665.8K2,389.46%2.51M-43,607.53%-13.4M-10,480.11%-3.24M---9.91M---137.67K---109.57K
Financing cash flow
Cash flow from continuing financing activities 2.35M85.64K1.85M000
Net common stock issuance --2.35M--85.64K--1.85M----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow --2.35M--85.64K--1.85M--411.7K--0--0--0--0--0--0
Net cash flow
Beginning cash position -91.85%1.71M-62.93%2.44M-90.05%1.78M-90.50%1.84M-92.03%1.68M586.11%21.03M481.84%6.57M919.49%17.93M672.62%19.32M586.11%21.03M
Current changes in cash 95.72%-826.83K67.34%-1.59M105.75%653.22K96.20%-52.82K109.38%159.89K-207.52%-19.31M-124.42%-4.86M-1,705.09%-11.36M-87.21%-1.39M-202.32%-1.7M
End cash Position -48.25%886.95K-48.25%886.95K-62.93%2.44M-90.05%1.78M-90.50%1.84M-91.85%1.71M-91.85%1.71M481.84%6.57M919.49%17.93M672.62%19.32M
Free cash flow -3.90%-6.6M-0.56%-1.84M16.63%-1.19M16.52%-1.16M-41.34%-2.41M-89.06%-6.35M-55.93%-1.83M-126.74%-1.43M-87.21%-1.39M-109.44%-1.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg